Is there scope for cost savings and efficiency gains in HIV services? A systematic review of the evidence from low- and middle-income countries;Est-il possible de faire des économies et d'obtenir des gains en termes d'efficacité dans les services anti-VIH? Un examen systématique des éléments de preuve dans les pays à revenu faible et intermédiaire

Bulletin of the World Health Organization

Volumn 92, Issue 7, 2014, Pages

  Siapka, Mariana ^a   Remme, Michelle ^a   Obure, Carol Dayo ^a   Maier, Claudia B ^b   Dehne, Karl L ^b   Vassall, Anna ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHECKLIST; COST EFFECTIVENESS ANALYSIS; COST SAVING; COUNSELING; DATA EXTRACTION; DRUMMONDS CHECKLIST; ECONOMIC EVALUATION; HEALTH ECONOMICS; HEALTH PROGRAM; HEALTH SERVICE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INCOME; LOW INCOME COUNTRY; MIDDLE INCOME COUNTRY; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; VIRUS TRANSMISSION; COST BENEFIT ANALYSIS; COST CONTROL; DEVELOPING COUNTRY; ECONOMICS; HEALTH SERVICES RESEARCH; HIV INFECTIONS; INTEGRATED HEALTH CARE SYSTEM;

HUMAN IMMUNODEFICIENCY VIRUS;

COST SAVINGS; COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE, INTEGRATED; DEVELOPING COUNTRIES; HEALTH SERVICES RESEARCH; HIV INFECTIONS; HUMANS;

EID: 84903557865     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.13.127639     Document Type: Review

References (103)

1. The Millennium Development Goals report 2012. New York (NY): United Nations; 2012.
2. 2011 United Nations General Assembly Political Declaration on HIV/AIDS. Geneva: Joint United Nations Programme on HIV/AIDS; 2011.
3. Creese A, Floyd K, Alban A, Guinness L. Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence. Lancet. 2002;359:1635-43. doi: http://dx.doi.org/10.1016/S0140-6736(02)08595-1 PMID: 12020523
4. Galárraga O, Colchero MA, Wamai RG, Bertozzi SM. HIV prevention cost-effectiveness: a systematic review. BMC Public Health. 2009;9 Suppl 1;S5. doi: http://dx.doi.org/10.1186/1471-2458-9-S1-S5 PMID: 19922689
5. Financing global health 2012: the end of the golden age? Seattle (WA): Institute for Health Metrics and Evaluation; 2012.
6. Together we will end AIDS. Geneva: Joint United Nations Programme on HIV/AIDS; 2012.
7. Galárraga O, Wirtz VJ, Figueroa-Lara A, Santa-Ana-Tellez Y, Coulibaly I, Viisainen K, et al. Unit costs for delivery of antiretroviral treatment and prevention of mother-to-child transmission of HIV: a systematic review for low-and middle-income countries. Pharmacoeconomics. 2011;29:579-99. PMID: 21671687
8. Johns B, Torres TT; WHO-CHOICE. Costs of scaling up health interventions: a systematic review. Health Policy Plan. 2005;20:1-13. doi: http://dx.doi.org/10.1093/heapol/czi001 PMID: 15689425
9. Sweeney S, Obure CD, Maier CB, Greener R, Dehne K, Vassall A. Costs and efficiency of integrating HIV/AIDS services with other health services: a systematic review of evidence and experience. Sex Transm Infect. 2012;88:85-99. doi: http://dx.doi.org/10.1136/sextrans-2011-050199 PMID: 22158934
10. Uyei J, Coetzee D, Macinko J, Guttmacher S. Integrated delivery of HIV and tuberculosis services in sub-Saharan Africa: a systematic review. Lancet. Infect Dis. 2011;11:855-67. doi: http://dx.doi.org/10.1016/S1473-3099(11)70145-1 PMID: 22035614
11. Vassall A, Compernolle P. Estimating the resource needs of scaling-up HIV/AIDS and tuberculosis interventions in sub-Saharan Africa: a systematic review for national policy makers and planners. Health Policy. 2006;79:1-15. doi: http://dx.doi.org/10.1016/j.healthpol.2005.11.005 PMID: 16388874
12. Walker D. Cost and cost-effectiveness of HIV/AIDS prevention strategies in developing countries: is there an evidence base? Health Policy Plan. 2003;18:4-17. doi: http://dx.doi.org/10.1093/heapol/18.1.4 PMID: 12582104
13. Santa-Ana-Tellez Y, DeMaria LM, Galárraga O. Costs of interventions for AIDS orphans and vulnerable children. Trop Med Int Health. 2011;16:1417-26. doi: http://dx.doi.org/10.1111/j.1365-3156.2011.02856.x PMID: 21859439
14. Zeng W, Shepard DS, Chilingerian J, Avila-Figueroa C. How much can we gain from improved efficiency? An examination of performance of national HIV/AIDS programs and its determinants in low-and middle-income countries. BMC Health Serv Res. 2012;12:74. doi: http://dx.doi.org/10.1186/1472-6963-12-74 PMID: 22443135
15. Schwartländer B, Stover J, Hallett T, Atun R, Avila C, Gouws E, et al.; Investment Framework Study Group. Towards an improved investment approach for an effective response to HIV/AIDS. Lancet. 2011;377:2031-41. doi: http://dx.doi.org/10.1016/S0140-6736(11)60702-2 PMID: 21641026
16. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097. doi: http://dx.doi.org/10.1371/journal.pmed.1000097 PMID: 19621072
17. Shepperd S, Lewin S, Straus S, Clarke M, Eccles MP, Fitzpatrick R, et al. Can we systematically review studies that evaluate complex interventions? PLoS Med. 2009;6:e1000086. doi: http://dx.doi.org/10.1371/journal.pmed.1000086 PMID: 19668360
18. How we classify countries [Internet]. Washington (DC): World Bank; 2012. Available from: http://data.worldbank.org/about/country-classifications [cited 2013 Oct 19].
19. Drummond MF, Jefferson TO; The BMJ Economic Evaluation Working Party. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ. 1996;313:275-83. doi: http://dx.doi.org/10.1136/bmj.313.7052.275 PMID: 8704542
20. Menzies NA, Berruti AA, Berzon R, Filler S, Ferris R, Ellerbrock TV, et al. The cost of providing comprehensive HIV treatment in PEPFAR-supported programs. AIDS. 2011;25:1753-60. doi: http://dx.doi.org/10.1097/QAD.0b013e3283463eec PMID: 21412127
21. Bikilla AD, Jerene D, Robberstad B, Lindtjorn B. Cost estimates of HIV care and treatment with and without anti-retroviral therapy at Arba Minch Hospital in southern Ethiopia. Cost Eff Resour Alloc. 2009;7:6. doi: http://dx.doi.org/10.1186/1478-7547-7-6 PMID: 19364399
22. Kombe G, Galaty D, Gadhia R, Decker C. The human and financial resource requirements for scaling up HIV/AIDS services in Ethiopia. Bethesda (MD): Abt Associates; 2005. Available from: http://www.abtassociates.com/reports/AB_PNADC109.pdf [cited 2013 Oct 19].
23. Marseille EA, Kevany S, Ahmed I, Feleke G, Graham B, Heller T, et al. Case management to improve adherence for HIV-infected patients receiving antiretroviral therapy in Ethiopia: a micro-costing study. Cost Eff Resour Alloc. 2011;9:18. doi: http://dx.doi.org/10.1186/1478-7547-9-18 PMID: 22185656
24. Cleary S, Tshehlo R, Jouquet G, Makakole L. Ensuring access to free HIV/AIDS care and treatment in Lesotho. Cape Town: University of Cape Town; 2007. Available from: http://196.202.240.21/mcaweb/documents/Health/HEALTH%20Decentralization%20of%20ART.pdf [cited 2013 Oct 19].
25. Cleary SM, McIntyre D, Boulle AM. The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa-a primary data analysis. Cost Eff Resour Alloc. 2006;4:20. doi: http://dx.doi.org/10.1186/1478-7547-4-20 PMID: 17147833
26. Deghaye N, Pawinski RA, Desmond C. Financial and economic costs of scaling up the provision of HAART to HIV-infected health care workers in KwaZulu-Natal. S Afr Med J. 2006;96:140-3. PMID: 16532083
27. Harling G, Bekker LG, Wood R. Cost of a dedicated ART clinic. S Afr Med J. 2007;97:593-6. PMID: 17952216
28. Harling G, Wood R. The evolving cost of HIV in South Africa: changes in health care cost with duration on antiretroviral therapy for public sector patients. J Acquir Immune Defic Syndr. 2007;45:348-54. PMID: 17496562
29. Rosen S, Long L, Sanne I. The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa. Trop Med Int Health. 2008;13:1005-15. doi: http://dx.doi.org/10.1111/j.1365-3156.2008.02114.x PMID: 18631314
30. Vella V, Govender T, Dlamini S, Taylor M, Moodley I, David V, et al. Evaluation of antiretroviral therapy against HIV/Aids in KwaZulu-Natal, South Africa. Pietermaritzburg: KwaZulu-Natal Department of Health; 2008. Available from: http://www.kznhealth.gov.za/italian/arv.pdf [cited 2013 Oct 19].
31. Kevany S, Meintjes G, Rebe K, Maartens G, Cleary S. Clinical and financial burdens of secondary level care in a public sector antiretroviral roll-out setting (G.F. Jooste Hospital). S Afr Med J. 2009;99:320-5. PMID: 19588792
32. Martinson N, Mohapi L, Bakos D, Gray GE, McIntyre JA, Holmes CB. Costs of providing care for HIV-infected adults in an urban HIV clinic in Soweto, South Africa. J Acquir Immune Defic Syndr. 2009;50:327-30. doi: http://dx.doi.org/10.1097/QAI.0b013e3181958546 PMID: 19194308
33. Long L, Fox M, Sanne I, Rosen S. The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa. AIDS. 2010;24:915-9. doi: http://dx.doi.org/10.1097/QAD.0b013e3283360976 PMID: 20042849
34. Long L, Brennan A, Fox MP, Ndibongo B, Jaffray I, Sanne I, et al. Treatment outcomes and cost-effectiveness of shifting management of stable ART patients to nurses in South Africa: an observational cohort. PLoS Med. 2011;8:e1001055. doi: http://dx.doi.org/10.1371/journal.pmed.1001055 PMID: 21811402
35. Babigumira JB, Sethi AK, Smyth KA, Singer ME. Cost effectiveness of facility-based care, home-based care and mobile clinics for provision of antiretroviral therapy in Uganda. Pharmacoeconomics 2009;27:963-73. doi: http://dx.doi.org/10.2165/11318230-000000000-00000 PMID: 19888795
36. Jaffar S, Amuron B, Foster S, Birungi J, Levin J, Namara G, et al.; Jinja Trial Team. Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet. 2009;374:2080-9. doi: http://dx.doi.org/10.1016/S0140-6736(09)61674-3 PMID: 19939445
37. Bratt JH, Torpey K, Kabaso M, Gondwe Y. Costs of HIV/AIDS outpatient services delivered through Zambian public health facilities. Trop Med Int. Health 2011;16:110-8. doi: http://dx.doi.org/10.1111/j.1365-3156.2010.02640.x PMID: 20958891
38. Hounton SH, Akonde A, Zannou DM, Bashi J, Meda N, Newlands D. Costing universal access of highly active antiretroviral therapy in Benin. AIDS Care. 2008;20:582-7. doi: http://dx.doi.org/10.1080/09540120701868303 PMID: 18484329
39. Renaud A, Basenya O, de Borman N, Greindl I, Meyer-Rath G. The cost effectiveness of integrated care for people living with HIV including antiretroviral treatment in a primary health care centre in Bujumbura, Burundi. AIDS Care. 2009;21:1388-94. doi: http://dx.doi.org/10.1080/09540120902884042 PMID: 20024715
40. Kombe G, Galaty D, Nwagbara C. Scaling-up antiretroviral treatment in the public sector in Nigeria: a comprehensive analysis of resource requirements [Internet]. Bethesda (MD): Abt Associates; 2004. Available from: http://www.healthsystems2020.org/content/resource/detail/1489/ [cited 2013 Oct 19].
41. Partners for Health Reformplus. Nigeria: rapid assessment of HIV/AIDS care in the public and private sectors [Internet]. Bethesda (MD): Abt Associates; 2004. Available from: http://www.healthsystems2020.org/content/resource/detail/1619/ [cited 2013 Oct 19].
42. Aliyu HB, Chuku NN, Kola-Jebutu A, Abubakar Z, Torpey K, Chabikuli ON. What is the cost of providing outpatient HIV counseling and testing and antiretroviral therapy services in selected public health facilities in Nigeria? J Acquir Immune Defic Syndr. 2012;61:221-5. doi: http://dx.doi.org/10.1097/QAI.0b013e3182683b04 PMID: 22820805
43. Gupta I, Trivedi M, Kandamuthan S. Recurrent costs of India's free ART program. In: Haacker M, Claeson M, editors. HIV and AIDS in South Asia: an economic development risk. Washington: World Bank; 2009. pp. 191-237.
44. John KR, Rajagopalan N, Madhuri KV. Brief communication: economic comparison of opportunistic infection management with antiretroviral treatment in people living with HIV/AIDS presenting at an NGO clinic in Bangalore, India. MedGenMed. 2006;8:24. PMID: 17415293
45. Kitajima T, Kobayashi Y, Chaipah W, Sato H, Chadbunchachai W, Thuennadee R. Costs of medical services for patients with HIV/AIDS in Khon Kaen, Thailand. AIDS. 2003;17:2375-81. doi: http://dx.doi.org/10.1097/00002030-200311070-00013 PMID: 14571190
46. Koenig SP, Riviere C, Leger P, Severe P, Atwood S, Fitzgerald DW, et al. The cost of antiretroviral therapy in Haiti. Cost Eff Resour Alloc. 2008;6:3. doi: http://dx.doi.org/10.1186/1478-7547-6-3 PMID: 18275615
47. Marques HH, Couttolenc BF, Latorre MdoR, Aquino MZ, Aveiro MI, Pluciennik AM. Costs of care provided in a university hospital for children exposed to or infected with the HIV/AIDS. Cad Saude Publica. 2007;23 Suppl 3;S402-13. doi: http://dx.doi.org/10.1590/S0102-311X2007001500008 PMID: 17992346
48. Aracena-Genao B, Navarro JO, Lamadrid-Figueroa H, Forsythe S, Trejo-Valdivia B. Costs and benefits of HAART for patients with HIV in a public hospital in Mexico. AIDS. 2008;22 Suppl 1;S141-8. doi: http://dx.doi.org/10.1097/01.aids.0000327635.74919.fd PMID: 18664946
49. Bautista SA, Dmytraczenko T, Kombe G, Bertozzi SM. Costing of HIV/AIDS treatment in Mexico. Bethesda (MD): Abt Associates; 2003. Available from: www.healthsystems2020.org/files/1574_file_Tech020_fin.pdf [cited 2013 Oct 19].
50. Contreras-Hernandez I, Becker D, Chancellor J, Kühne F, Mould-Quevedo J, Vega G, et al. Cost-effectiveness of maraviroc for antiretroviral treatment-experienced HIV-infected individuals in Mexico. Value Health. 2010;13:903-14. doi: http://dx.doi.org/10.1111/j.1524-4733.2010.00798.x PMID: 21091827
51. Loubiere S, el Filal KM, Sodqi M, Loundou A, Luchini S, Cleary S, et al. When to initiate highly active antiretroviral therapy in low-resource settings: the Moroccan experience. Antivir Ther. 2008;13:241-51. PMID: 18505175
52. Hsu J, Zinsou C, Parkhurst J, N'Dour M, Foyet L, Mueller DH. Comparative costs and cost-effectiveness of behavioural interventions as part of HIV prevention strategies. Health Policy Plan. 2013;28:20-9. doi: http://dx.doi.org/10.1093/heapol/czs021 PMID: 22411881
53. Söderlund N, Lavis J, Broomberg J, Mills A. The costs of HIV prevention strategies in developing countries. Bull World Health Organ. 1993;71:595-604. PMID: 8261563
54. Terris-Prestholt F, Kumaranayake L, Foster S, Kamali A, Kinsman J, Basajja V, et al. The role of community acceptance over time for costs of HIV and STI prevention interventions: analysis of the Masaka Intervention Trial, Uganda, 1996-1999. Sex Transm Dis. 2006;33 Suppl;S111-6. doi: http://dx.doi.org/10.1097/01.olq.0000175389.10289.ba PMID: 16505738
55. Terris-Prestholt F, Kumaranayake L, Obasi AI, Cleophas-Mazige B, Makokha M, Todd J, et al. From trial intervention to scale-up: costs of an adolescent sexual health program in Mwanza, Tanzania. Sex Transm Dis. 2006;33 Suppl;S133-9. doi: http://dx.doi.org/10.1097/01.olq.0000200606.98181.42 PMID: 16652070
56. Dandona L, Kumar SG, Kumar GA, Dandona R. Cost-effectiveness of HIV prevention interventions in Andhra Pradesh state of India. BMC Health Serv Res. 2010;10:117. doi: http://dx.doi.org/10.1186/1472-6963-10-117 PMID: 20459755
57. Twahir A, Maggwa BN, Askew I. Integration of STI and HIV/AIDS services with MCH-FP services: a case study of the Mkomani Clinic Society in Mombasa, Kenya. Washington (DC): Population Council; 1996. Available from: http://www.popcouncil.org/pdfs/frontiers/fphivintegrat/Mombassa96.pdf [cited 2013 Oct 19].
58. Sweat M, Gregorich S, Sangiwa G, Furlonge C, Balmer D, Kamenga C, et al. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet. 2000;356:113-21. doi: http://dx.doi.org/10.1016/S0140-6736(00)02447-8 PMID: 10963247
59. Forsythe S, Arthur G, Ngatia G, Mutemi R, Odhiambo J, Gilks C. Assessing the cost and willingness to pay for voluntary HIV counselling and testing in Kenya. Health Policy Plan. 2002;17:187-95. doi: http://dx.doi.org/10.1093/heapol/17.2.187 PMID: 12000779
60. John FN, Farquhar C, Kiarie JN, Kabura MN, John-Stewart GC. Cost effectiveness of couple counselling to enhance infant HIV-1 prevention. Int J STD AIDS. 2008;19:406-9. doi: http://dx.doi.org/10.1258/ijsa.2008.007234 PMID: 18595879
61. Liambila W, Askew I, Ayisi R, Gathitu M, Mwangi J, Homan R, et al. Feasibility, acceptability, effect and cost of integrating counseling and testing for HIV within family planning services in Kenya. Washington (DC): Population Council; 2008. Available from: http://www.popcouncil.org/pdfs/frontiers/FR_FinalReports/Kenya_CT_FP.pdf [cited 2013 Oct 19].
62. Negin J, Wariero J, Mutuo P, Jan S, Pronyk P. Feasibility, acceptability and cost of home-based HIV testing in rural Kenya. Trop Med Int Health. 2009;14:849-55. doi: http://dx.doi.org/10.1111/j.1365-3156.2009.02304.x PMID: 19552646
63. Grabbe KL, Menzies N, Taegtmeyer M, Emukule G, Angala P, Mwega I, et al. Increasing access to HIV counseling and testing through mobile services in Kenya: strategies, utilization, and cost-effectiveness. J Acquir Immune Defic Syndr. 2010;54:317-23. doi: http://dx.doi.org/10.1097/QAI.0b013e3181ced126 PMID: 20453819
64. Obure CD, Vassall A, Michaels C, Terris-Prestholt F, Mayhew S, Stackpool-Moore L, et al.; Integra Research Team. Optimising the cost and delivery of HIV counselling and testing services in Kenya and Swaziland. Sex Transm Infect. 2012;88:498-503. doi: http://dx.doi.org/10.1136/sextrans-2012-050544 PMID: 22859498
65. McConnel CE, Stanley N, du Plessis JA, Pitter CS, Abdulla F, Coovadia HM, et al. The cost of a rapid-test VCT clinic in South Africa. S Afr Med J. 2005;95:968-71. PMID: 16465359
66. Hausler HP, Sinanovic E, Kumaranayake L, Naidoo P, Schoeman H, Karpakis B, et al. Costs of measures to control tuberculosis/HIV in public primary care facilities in Cape Town, South Africa. Bull World Health Organ. 2006;84:528-36. doi: http://dx.doi.org/10.2471/BLT.04.018606 PMID: 16878226
67. Menzies N, Abang B, Wanyenze R, Nuwaha F, Mugisha B, Coutinho A, et al. The costs and effectiveness of four HIV counseling and testing strategies in Uganda. AIDS. 2009;23:395-401. doi: http://dx.doi.org/10.1097/QAD.0b013e328321e40b PMID: 19114865
68. Tumwesigye E, Wana G, Kasasa S, Muganzi E, Nuwaha F. High uptake of home-based, district-wide, HIV counseling and testing in Uganda. AIDS Patient Care STDS. 2010;24:735-41. doi: http://dx.doi.org/10.1089/apc.2010.0096 PMID: 21067357
69. Dandona L, Sisodia P, Ramesh YK, Kumar SG, Kumar AA, Rao MC, et al. Cost and efficiency of HIV voluntary counselling and testing centres in Andhra Pradesh, India. Natl Med J India. 2005;18:26-31. PMID: 15835489
70. Das R, Biswas K, Panda P, Khan ME, Homan R. Strengthening financial sustainability through integration of voluntary counseling and testing services with other reproductive health services. Washington (DC): Population Council; 2007. Available from: http://www.popcouncil.org/pdfs/frontiers/FR_FinalReports/India_CINI.pdf [cited 2013 Oct 19].
71. Moses S, Plummer FA, Ngugi EN, Nagelkerke NJ, Anzala AO, Ndinya-Achola JO. Controlling HIV in Africa: effectiveness and cost of an intervention in a high-frequency STD transmitter core group. AIDS. 1991;5:407-11. doi: http://dx.doi.org/10.1097/00002030-199104000-00008 PMID: 1905555
72. Chang LW, Kagaayi J, Nakigozi G, Serwada D, Quinn TC, Gray RH, et al. Cost analyses of peer health worker and mHealth support interventions for improving AIDS care in Rakai, Uganda. AIDS Care. 2013;25:652-6. doi: http://dx.doi.org/10.1080/09540121.2012.722600 PMID: 22971113
73. Guinness L, Vickerman P, Quayyum Z, Foss A, Watts C, Rodericks A, et al. The cost-effectiveness of consistent and early intervention of harm reduction for injecting drug users in Bangladesh. Addiction. 2010;105:319-28. doi: http://dx.doi.org/10.1111/j.1360-0443.2009.02755.x PMID: 19922513
74. Dandona L, Sisodia P, Kumar SG, Ramesh YK, Kumar AA, Rao MC, et al. HIV prevention programmes for female sex workers in Andhra Pradesh, India: outputs, cost and efficiency. BMC Public Health. 2005;5:98. doi: http://dx.doi.org/10.1186/1471-2458-5-98 PMID: 16181491
75. Guinness L, Kumaranayake L, Rajaraman B, Sankaranarayanan G, Vannela G, Raghupathi P, et al. Does scale matter? The costs of HIV-prevention interventions for commercial sex workers in India. Bull World Health Organ. 2005;83:747-55. PMID: 16283051
76. Fung IC, Guinness L, Vickerman P, Watts C, Vannela G, Vadhvana J, et al. Modelling the impact and cost-effectiveness of the HIV intervention programme amongst commercial sex workers in Ahmedabad, Gujarat, India. BMC Public Health. 2007;7:195. doi: http://dx.doi.org/10.1186/1471-2458-7-195 PMID: 17683595
77. Dandona L, Kumar SP, Ramesh Y, Rao MC, Kumar AA, Marseille E, et al. Changing cost of HIV interventions in the context of scaling-up in India. AIDS. 2008;22 Suppl 1;S43-9. doi: http://dx.doi.org/10.1097/01.aids.0000327622.24232.aa PMID: 18664952
78. Kumar SG, Dandona R, Schneider JA, Ramesh YK, Dandona L. Outputs and cost of HIV prevention programmes for truck drivers in Andhra Pradesh, India. BMC Health Serv Res. 2009;9:82. doi: http://dx.doi.org/10.1186/1472-6963-9-82 PMID: 19457269
79. Chandrashekar S, Guinness L, Kumaranayake L, Reddy B, Govindraj Y, Vickerman P, et al. The effects of scale on the costs of targeted HIV prevention interventions among female and male sex workers, men who have sex with men and transgenders in India. Sex Transm Infect. 2010;86 Suppl 1;i89-94. doi: http://dx.doi.org/10.1136/sti.2009.038547 PMID: 20167740
80. Siregar AY, Komarudin D, Wisaksana R, van Crevel R, Baltussen R. Costs and outcomes of VCT delivery models in the context of scaling up services in Indonesia. Trop Med Int Health. 2011;16:193-9. doi: http://dx.doi.org/10.1111/j.1365-3156.2010.02675.x PMID: 21070513
81. Kumaranayake L, Vickerman P, Walker D, Samoshkin S, Romantzov V, Emelyanova Z, et al. The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, Belarus. Addiction. 2004;99:1565-76. doi: http://dx.doi.org/10.1111/j.1360-0443.2004.00899.x PMID: 15585048
82. Vickerman P, Kumaranayake L, Balakireva O, Guinness L, Artyukh O, Semikop T, et al. The cost-effectiveness of expanding harm reduction activities for injecting drug users in Odessa, Ukraine. Sex Transm Dis. 2006;33 Suppl;S89-102. doi: http://dx.doi.org/10.1097/01.olq.0000221335.80508.fa PMID: 16735956
83. Unit cost repository [Internet]. Glastonbury: Futures Institute; 2010. Available from: http://policytools.futuresinstitute.org/UC/unit_cost_db.aspx [cited 2013 Oct 19].
84. Binagwaho A, Pegurri E, Muita J, Bertozzi S. Male circumcision at different ages in Rwanda: a cost-effectiveness study. PLoS Med. 2010;7:e1000211. doi: http://dx.doi.org/10.1371/journal.pmed.1000211 PMID: 20098721
85. Martin G, Bollinger L, Pandit-Rajani T, Tshehlo R, Stover J. Costing male circumcision in Lesotho and implications for the cost-effectiveness of circumcision as an HIV intervention. Washington (DC): United States Agency for International Development; 2007. Available from: http://www.aidstar-one.com/sites/default/files/410_1_Lesotho_MC_Costing_FINAL_10_11_07.pdf [cited 2013 Oct 19].
86. Bollinger L, Stover, J. The potential cost and impact of expanding male circumcision in South Africa. Washington (DC): United States Agency for International Development; 2010. Available from: http://www.malecircumcision.org/programs/documents/South_Africa11209.pdf [cited 2013 Oct 19].
87. Assessing potential impact and costs of scaling-up medical male circumcision services in Uganda. Washington (DC): United States Agency for International Development; 2010.
88. Costing male circumcision in Zimbabwe and impacts of scaling up the circumcision program. Washington (DC): United States Agency for International Development; 2010.
89. Orlando S, Marazzi MC, Mancinelli S, Liotta G, Ceffa S, Giglio P, et al. Cost-effectiveness of using HAART in prevention of mother-to-child transmission in the DREAM-Project Malawi. J Acquir Immune Defic Syndr. 2010;55:631-4. doi: http://dx.doi.org/10.1097/QAI.0b013e3181f9f9f5 PMID: 21934555
90. Desmond C, Franklin L, Steinberg M. The prevention of mother-to-child HIV transmission: costing the service in four sites in South Africa. Durban: Health Systems Trust; 2004. Available from: http://www.hst.org.za/sites/default/files/PMTCT_Costing.pdf [cited 2013 Oct 19].
91. Dandona L, Kumar SG, Ramesh YK, Rao MC, Marseille E, Kahn JG, et al. Outputs, cost and efficiency of public sector centres for prevention of mother to child transmission of HIV in Andhra Pradesh, India. BMC Health Serv Res. 2008;8:26. doi: http://dx.doi.org/10.1186/1472-6963-8-26 PMID: 18234117
92. Bautista-Arredondo S, Dmytraczenko T, Kombe G, Bertozzi SM. Costing of scaling up HIV/AIDS treatment in Mexico. Salud Publica Mex. 2008;50 Suppl 4;S437-44. doi: http://dx.doi.org/10.1590/S0036-36342008001000004 PMID: 19082254
93. Menzies NA, Berruti AA, Blandford JM. The determinants of HIV treatment costs in resource limited settings. PLoS One. 2012;7:e48726. doi: http://dx.doi.org/10.1371/journal.pone.0048726 PMID: 23144946
94. McMennamin T, Alexander F, Fritsche G. Rwanda HIV/PBF Project: cost and revenue analysis in six Rwandan health centers: 2005 costs and revenues. Washington: United States Agency for International Development; 2007. Available from: http://www.umuganga.com/docs/statiscs1.pdf [cited 2013 Oct 19].
95. Minh HV, Bach TX, Mai NY, Wright P. The cost of providing HIV/AIDS counseling and testing services in Vietnam. Value in Health Regional Issues. 2012;1:36-40. doi: http://dx.doi.org/10.1016/j.vhri.2012.03.012
96. Marseille E, Dandona L, Marshall N, Gaist P, Bautista-Arredondo S, Rollins B, et al. HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries. BMC Health Serv Res. 2007;7:108. doi: http://dx.doi.org/10.1186/1472-6963-7-108 PMID: 17626616
97. Wilkinson D, Floyd K, Gilks CF. Antiretroviral drugs as a public health intervention for pregnant HIV-infected women in rural South Africa: an issue of cost-effectiveness and capacity. AIDS. 1998;12:1675-82. doi: http://dx.doi.org/10.1097/00002030-199813000-00016 PMID: 9764788
98. Robberstad B, Evjen-Olsen B. Preventing mother to child transmission of HIV with highly active antiretroviral treatment in Tanzania-a prospective cost-effectiveness study. J Acquir Immune Defic Syndr. 2010;55:397-403. doi: http://dx.doi.org/10.1097/QAI.0b013e3181eef4d3 PMID: 20739897
99. Stringer EM, Sinkala M, Stringer JS, Mzyece E, Makuka I, Goldenberg RL, et al. Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, Zambia. AIDS. 2003;17:1377-82. doi: http://dx.doi.org/10.1097/00002030-200306130-00012 PMID: 12799559
100. Nakakeeto ON, Umaranayake L. The global strategy to eliminate HIV infection in infants and young children: a seven-country assessment of costs and feasibility. AIDS. 2009;23:987-95. doi: http://dx.doi.org/10.1097/QAD.0b013e32832a17e9 PMID: 19425224
101. Task shifting: rational redistribution of tasks among health workforce teams: global recommendations and guidelines. Geneva: World Health Organization; 2008.
102. Zachariah R, Ford N, Philips M, Lynch S, Massaquoi M, Janssens V, et al. Task shifting in HIV/AIDS: opportunities, challenges and proposed actions for sub-Saharan Africa. Trans R Soc Trop Med Hyg. 2009;103:549-58. doi: http://dx.doi.org/10.1016/j.trstmh.2008.09.019 PMID: 18992905
103. Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, Nash D, et al.; ART-LINC, IeDEA. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ. 2008;86:559-67. doi: http://dx.doi.org/10.2471/BLT.07.044248 PMID: 18670668